.BETA.-D-GLUCOPYRANURONIC ACID, 1-(2,3-DIHYDRO-3,3-DIMETHYL-6-(((2-((4-PYRIDINYLMETHYL)AMINO)-3-PYRIDINYL)CARBONYL)AMINO)-1H-INDOLE-1-CARBOXYLATE)
UNII 1O95S36Q60

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-d-glucopyranuronic Acid, 1-(2,3-dihydro-3,3-dimethyl-6-(((2-((4-pyridinylmethyl)amino)-3-pyridinyl)carbonyl)amino)-1h-indole-1-carboxylate), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1O95S36Q60.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1182283-88-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1O95S36Q60

CAS Registry Number

1182283-88-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-D-GLUCOPYRANURONIC ACID, 1-(2,3-DIHYDRO-3,3-DIMETHYL-6-(((2-((4-PYRIDINYLMETHYL)AMINO)-3-PYRIDINYL)CARBONYL)AMINO)-1H-INDOLE-1-CARBOXYLATE)

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H31N5O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PZEXFDFEUNSUKB-LHAUQXRRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

154572896

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(c(nc1)NCc2ccncc2)C(Nc3cc4c(cc3)C(CN4C(O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)C(=O)O)=O)(C)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranuronic Acid, 1-(2,3-dihydro-3,3-dimethyl-6-(((2-((4-pyridinylmethyl)amino)-3-pyridinyl)carbonyl)amino)-1h-indole-1-carboxylate). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.